Doctor Kirstin Stricker
Novartis Pharma, Basel (Switzerland)
Large number of real world evidence studies confirmed effectiveness and safety in treatment with Val/Aml and Val/Aml/HCT worldwide across various ethical groups, disease severities and co-morbidities
Event: ESC Congress 2017
Topic: Treatment of hypertension
Session: Hypertension drug treatment
ESC 365 is supported by
